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Table 1
Group 1 (Psoriatic) (n=115) Group 2 (Control) (n=60) p
Age (years) 33.6  6.0 32.5  8.3 NS
Male gender (%) 62 (53.9%) 28 (46.7%) NS
Current smoker (%) 46.9 (54/115) 38.3 (23/60) NS
Family history of CAD (%) 18.3 (21/115) 16.7 (10/60) NS
BMI (kg/m2) 26.1  3.1 25.2  3.2 NS
Waist circumference (cm) 92.3  10.1 88.7  11.9 NS
Ofﬁce SBP (mmHg) 121.9  10.6 118.3  11.6 NS
Ofﬁce DBP (mmHg) 75.8  8.7 73.2  9.6 NS
HR (bpm) 78.5  9.9 74.1  11.5 NS
Fasting glucose (mg/dL) 92.2  11.6 88.5  12.7 NS
Total cholesterol (mg/dL) 185.4  37.4 179.1  33.8 NS
Serum LDL cholesterol (mg/dL) 129.4  33.7 127.7  26.1 NS
Serum HDL cholesterol (mg/dL) 49.2  12.9 48.4  13.5 NS
Serum triglycerides (mg/dL) 125.3  77.3 126.2  67.0 NS
Sedimentation (mm/h) 14.4  10.2 11.0  9.6 NS
hsCRP (mg/dL) 0.52  0.45 0.19  0.17 0.001





Group (n=46) P value
Age (years) 54.68.5 53.98.0 0.6
Female (%) 71.7 73.9 0.5
Duration of diabetes mellitus (month) 50.3 42.6 0.1
History of (%)
Hypertension 80.4 78.3 0.5
Smoke 28.3 19.6 0.2
Fasting glucose (mg/dL) 20280 18970 0.3
Creatinin (mg/dL) 0.860.19 0.880.19 0.4
Tryglyceride (mg/dL) 208115 18283 0.2
Total- Cholesterole (mg/dL) 20551 19945 0.5
Low Density Lipoprotein Cholesterole (mg/dL) 12437 11739 0.3
High Density Lipoprotein Cholesterole (mg/dL) 419 4310 0.5
HbA1c (%) 8.71.9 7.91.6 0.038
CRP (mg/dL) 5.5 5.0 4.5 5.1 0.3
Body Mass Index (kg/m2) 32.45.8 31.13.7 0.1
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Background: An increased cardiovascular risk has been evidenced in patients with
deep venous thrombosis. We aimed to investigate the relationship between the extent
of venous thromboembolism (VTE) and epicardial fat thickness (EFT) and carotid
intima-media thickness (CIMT).
Methods: In this study 38 patients with VTE (distal and proximal), and 37 age and sex
matched patients were enrolled as control group. The patients who had known coronary
artery diseases, had abnormal wall motion, and had history of angina were excluded.
Echocardiographic EFT and ultrasonographic CIMT were measured in all subjects.
Results: The study group consisted of 38 patients,with a mean age 5911,(55% male)
and 37 healty control groupwith amean age 5712 (54%male). Therewas no difference
between in diabetes mellitus. hypertension, smoking in two groups. Similarly, total
cholesterol, low density cholesterol high density cholesterol, and triglicerides levels did
not have any difference. According to control group EFT was signiﬁcantly higher than
VTE group (7.12.1 mm vs 5.32.5 mm, p¼0.001). Besides this according to control
groupCIMTwas signiﬁcantly higher thanVTEgroup. (0.910.34 cmvs 0.660.22 cm,
p<0.001).
Conclusıons: This study showed that surrogate markers of atherosclerosis were more
frequently seen in patientswith VTE. Themeasurement of EFT andCIMT,may represent
a useful and reliable method to evaluate cardiovascular risk in patients with VTE.
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Cardiovascular disease is the most important cause of mortality in patients with type
2 diabetes and is preceded by endothelial dysfunction.Epicardial adipose tissue has
shown to be related to cardiovascular risk. An increased epicardial adipose tissue is
associated with incident coronary artery disease and major adverse cardiac events. The
aim of the present study is to investigate the relationship between epicardial adipose
tissue and endothelial function in patients with type 2 Diabetes Mellitus (DM).
Methods: Type 2 DM patients were divided into two groups according to their
brachial ﬂow mediated dilatation values. The endothelial dysfunction group consisted
of 46 participants with ﬂow mediated dilatation change <7%, while 46 participants
with ﬂow-mediated dilatation change >7% were accepted as the non-endothelial
dysfunction group. Thickness of the epicardial adipose tissue (EAT) was measured to
right ventricular free wall adjacent to the parasternal long and short axis images. The
patients' demographic, anthropometric and laboratory ﬁndings were recorded.
Results: The mean FMD values of patients were 13.24.9% in Non-ED Group and
3.53.4% in ED Group (p<0.001). Table 1 shows the baseline characteristics of
patients. The EAT short and long axis diameters were shown in Figure 1. The HbA1c
levels were signiﬁcantly higher in ED Group than Non-ED Group (respectively,
8.71.9%, 7.91.6%, p<0.038). There were a negative correlation between FMD
values and EAT short and long axis diameters (respectively; r¼-0,349, p¼0.001, r¼-
0,351, p¼0.001). The hematologic parameters including; white blood count, hemo-
globine, platelet, lymphocyte count, red cell distribution width, mean platelet volume,JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTneutrophil lymphocyte ratio and platelet lymphocyte ratio were similar between two
groups. The neutrophil counts were higher in ED group than Non-ED Group
(47231651 vs 40911252, p¼0,041). In logistic regression analyses, HbA1c and
EAT short axis diameter were found as predictors for ED (CI 95% was 2,278 for
HbA1c, p¼0.006 and CI 95% was 2,953 for EAT short axis diameter, p¼0.0022).
Conclusıon: IncreasedEATdiameters andHbA1cpredict ED in patientswith type 2DM.PP-144
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Background: Heart failure (HF), which is a major cardiovascular health problem,
has still a poor prognosis despite advances in its management. Several studies
suggested that inﬂammation has an important role in HF progression. However, the
location of inﬂammation in diagnosis and treatment of patients with HF is still
unclear. Therefore, we aimed to compare inﬂammatory markers in patients with
ischemic and non-ischemic HF.
Methods: This study included 46 ischemic HF (33 male, age 6910 years) and 55
non-ischemic HF (35 male, age 6111 years) patients who had functional class I-II,
asymptomatic, low left ventricular ejection fraction (LV EF <40%). In addition, there
was no coronary artery disease or angiographycally signiﬁcant stenosis (50% in
diameter) in non-ischemic HF patients. An age, sex-matched control group was
composed of 40 (17 male, age 5813 years) patients. We evaluated clinical and
laboratory characteristics which are associated with inﬂammatory process such as red
blood cell distribution width (RDW), white blood cells (WBC), neutrophil-to-
lymphocyte counts (NLR), uric acit and high sensivity C reactive protein (Hs CRP).
Echocardiography was performed. The left atrial size, LV diameter and volumes, wall
thickness were measured. LV EF was calculated by Simpson's method.
Results: Age, diabetes mellitus, hyperlipidemia, systolic and diastolic blood pressure
were signiﬁcantly higher in HF group when compared with control group. LV EF
(29.64.8 vs 315, p¼0.20), diameters and volumes was similar between ischemic and
non ischemic HF groups. According to control group, RDW (15.81.9 vs 15.51.8 vs
141.5, p<0.05), neutrophil-to-lymphocit ratio [348 (169-768) vs 269 (65-722) vs 177
(58-268), p<0.05], uric acid (6.91.9 vs 6.11.8 vs 4.51.3 mg/dl, p<0.05) levels
were signiﬁcantly higher in heart failure groups., Hs CRP levels [18.8 (1.1-92.7) vs 8.7
(1-42) mg/L, p<0.05], NLR [348 (169-768) vs 269 (65-722), p<0.05] were signiﬁ-







SConclusıon: Our ﬁndings show that markers associated with inﬂammation in HF,
especially increase in patients with ischemic HF. Therefore, we believe that the
inﬂammatory process should be evaluated in diagnosis and treatment of patients with
HF. However, this result needs to be validated in large-sized studies.
Key words: Heart Failure, Inﬂammation, C reactive protein.
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Background: Total atrial conduction time (TACT) is the most important parameter
predicts the development of new-onset atrial ﬁbrillation. We investigate the effect of
cilastazol therapy on TACT in patients with peripheral artery disease.
Methods: Thirty patients with peripheral artery disease were treated with cilastazol
(200mg/day) for 6 months. Baseline echocardiographic total atrial conduction time
parameter was compared with the 6-month follow-up.
Results: The TACT duration (Figure 1) was decreased in all patients compared with
baseline after therapy (121.819.3 vs. 109.115.9 milliseconds, p<0.001). However,
LA diameter was not different at the sixth month of therapy compared with the
baseline. The reduction of TACT duration was correlated with the increase in mitral E
wave velocity/mitral A wave velocity ratio (r¼-0.48, P < 0.003) (Figure.2).
Conclusıon: Our result showed that 200-mg cilastazol treatment decreased TACT
duration in patients with peripheral artery disease, which suggest that there might be
a link with cilastazol treatment and atrial ﬁbrillation development and/or recurrence.PP-146
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sympathetic tone following an orthostatic maneuver. This pathological process mainly
related to a generalised involvement of the autonomic nervous system (ANS).
Increased mean platelet volume (MPV) may reﬂect increased platelet activation or
increased numbers of large, hyperaggregable platelets an, is accepted as an indepen-
dent cardiovscular risk factor. Increased sympathetic activity may have an important
role in MPV, either by peripheral activation and splenic release or by effects on
thrombocytopoiesis. Since sympathovagal balance is affected in patients with VVS, in
the present study, we aimed to show the effects of increased sympathetic activity on
platelet size during asymptomatic time periods in patients with VVS.
Materıal-Methods: Thirty seven patients with VVS were compared with age- and
sex-matched 33 patients without VVS. All patients were underwent into 24-hour
holter monitoring for assessing heart rate (HR) variability analysis. Time-domain
HRV analysis were done. Blood samples were taken for MPV measurements were
taken before the holter monitoring. Statistical analyses (Independent-Samples T test
and Chi-Square tests) were used to evaluate the differences between two groups.
Results: Group 1 was consisted of 37 patients with VVS (mean age 35,2720,09
years, 22 male (66,7%9)) and group 2 was consisted of 33 patients without VVS
(mean age 29,2711,68 years, 25 male (67,6%)). In terms of basal demographic
characteristics, there was no statistically signiﬁcant difference between two groups.
When we evaluated the time-domain HRV analysis parameters, we observed that
SDNN, SDNN index, SDSD, RMSDD, PNN50 count were signiﬁcantly lower in
patients with VVS (p<0.05 for all). Also, MPV was found signiﬁcantly higher in
patients with VVS. Pearson's correlation analysis showed that MPV was moderately
negatively correlated with SDNN (r¼-0,421), SDSD (r¼-0,396), NN50 count (r¼-
0,395), RMSDD (r¼-0,393). There was not a statistically signiﬁcant correlation
between MPV and time-domain HRV analysis parameters in patients without VVS.
Conclusıon: We found that MPV was signiﬁcantly higher in the patients with VVS,
and MPV is also closely associated with increased sympathetic activity in patients
with VVS. Our analysis supports the hypothesis that alterations of autonomic status
may play a role in the development of platelet size.PP-147
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Objectıve: To evaluate the relationship between the endothelial dysfunction assessed
by ﬂow mediated dilation (FMD) in the brachial artery and serum total antioxidant
status (TAS) in SLE patients.
Methods: Thirty-four patients with SLE and thirty-nine healthy volunteers without any
cardiovascular disease and atherosclerotic risk factorswere included in this study.Doppler
ultrasound system was used to measure FMD from the brachial artery in the antecubital
fossa to assess endothelial function. Serum TAS was measured with TAS kit. High-
sensitivity C-reactive protein (hs-CRP), a marker of inﬂammation, was also determined.
Results: The mean TAS value was signiﬁcantly lower in patients with SLE than in
controls (1.600.11 versus 1.730.15; p<0.0001). hs-CRP levels were signiﬁcantly
higher in patients with SLE than in controls (8.26.0 vs 2.94.0; p<0.0001). There was
no difference between groups regarding baseline and hyperemic diameters. However,
FMD percent was found to be signiﬁcantly lower in SLE patients than in controls. FMD
signiﬁcantly positively correlated with TAS (r¼0.448, p¼0.001) and signiﬁcantly
inversely correlated with serum hs-CRP levels (r¼-0.314, p¼0.001). In regression anal-
ysis, only TAS was independently correlated with FMD (b¼0.575, p¼0.002).
Conclusıon: SLEpatients without cardiovascular risk factors have endothelial dysfunction
and this can be releated with underlying inﬂammation and impairment of TAS.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
